Edoxaban

Details

Files

Generic Name:

Edoxaban

Project Status:

Complete

Therapeutic Area:

Venous thromboembolism, treatment and recurrence prevention.

Manufacturer:

Daiichi Sankyo, Inc.

Call for patient/clinician input open:

June 8, 2016

Brand Name:

Lixiana VTE

Project Line:

Reimbursement Review

Project Number:

SR0499-000

Call for patient/clinician input closed:

July 28, 2016

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Venous thromboembolism, treatment and recurrence prevention

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 25, 2017

Last Updated : June 8, 2016